Genscript Biotech (FRA:G51) Total Payout Ratio : 0.04 (As of Dec. 14, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Genscript Biotech Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Genscript Biotech's current Total Payout Ratio is 0.04.

Genscript Biotech Total Payout Ratio Historical Data

The historical data trend for Genscript Biotech's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Total Payout Ratio Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

Get a 7-Day Free Trial

-0.04

1.60

1.84

0.98

2.94

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Payout Ratio	Get a 7-Day Free Trial															0.02	2.07	4.18	0.07	0.02

Competitive Comparison of Genscript Biotech's Total Payout Ratio

For the Biotechnology subindustry, Genscript Biotech's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Total Payout Ratio falls into.

Genscript Biotech Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Genscript Biotech's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	944.664	+	0)	/	-321.848
	=	2.94

Genscript Biotech's Total Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	4.077	+	0)	/	-190.991
	=	0.02

Genscript Biotech Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (FRA:G51) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

GNNSF:USA 01548:Hong Kong

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend.

Genscript Biotech Headlines

No Headlines